Enertopia Announces Filing
of Provisional patent for V-LoveTM
Vancouver, BC -- October 26, 2015 -- InvestorsHub NewsWire --
Enertopia Corporation (ENRT-OTCBB) (TOP-CSE) (the
"Company" or "Enertopia") announces it has applied for patent
protection of V-LoveTM with respect to claims involving
lubrication, pH balance and the bioavailability of certain vitamins
and minerals via absorption through the vaginal mucosal
membrane.
Enertopia has filed a provisional patent application with the
United States Patent and Trademark Office regarding its
technology.
Enertopias patent-pending formulations were developed in part
with the goal of achieving much higher levels of lubrication, thus
reducing the potential for vaginal micro tears. However,
patent-pending these compositions also provide greater
bioavailability of ingredients such as water based vitamins via
absorption through the vaginal mucosal membrane than would
otherwise be absorbed by the daily oral intake of water based
vitamins.
It is in the Companys best interests to have filed the
provisional patent application to protect the Companys formulations
as evidence has shown that vaginal suppositories have had greater
bioavailability results than the common oral intake of water
soluble vitamins. The greater the opportunity for water soluble
based vitamins to replenish the body, the better the overall health
as water based vitamins need to be replenished on a daily
basis.
V-LoveTM is specifically balanced for a womans healthy vaginal
pH balance of 3.8 to 4.5. While this is on the acidic side of the
pH scale, it is nowhere near the acidity of the average stomach
acid that has a pH of 1.5. This allows for slower decay of vitamins
and minerals compared to oral intake, which in turn allows for
greater absorption potential over time. In addition, absorption
through the vaginal mucosal membrane avoids the first-pass
metabolism that occurs with oral administration of water soluble
vitamins (metabolism that occurs in the intestine and portal
circulation of the liver before reaching systemic circulation).
V-LoveTM patent-pending formulation meets the needs of providing
increased vaginal lubrication to decrease the chance of vaginal
micro tears and providing water based vitamins with increased
bioavailability, all under the protection of a healthy vaginal pH
balance.
These are exciting times for Enertopia. We are very proud about
our provisional patent application being filed and all the hard
work and dedication by our team. We look forward to providing
updates and further developments about our Company. Stated Robert
McAllister, President of Enertopia.
About Enertopia
The Companys mission is to empower people with a better way of
living through healthy lifestyle choices in helping you live your
life your way. Our core values of honesty, integrity, and
commitment help to define our corporate practices and demonstrate
our dedication in helping individuals whether they are encountering
health issues based on age, diet or have suffered a traumatic
physical, mental or an emotional event.
Enertopias shares are quoted in Canada with symbol TOP and in
the United States with symbol ENRT. For additional information,
please visit www.enertopia.com or v-love.co or call
Robert McAllister: (250) 765-6412
FORWARD-LOOKING STATEMENTS
This release includes forward-looking statements. Statements which
are not historical facts are forward-looking statements. The
Company makes forward-looking public statements concerning its
expected future financial position, results of operations, cash
flows, financing plans, business strategy, products and services,
competitive positions, growth opportunities, plans and objectives
of management for future operations, including statements that
include words such as anticipate, if, believe, plan, estimate,
expect, intend, may, could, should, will, and other similar
expressions are forward-looking statements. Such forward-looking
statements are estimates reflecting the Companys best judgment
based upon current information and involve a number of risks and
uncertainties, and there can be no assurance that other factors
will not affect the accuracy of such forward-looking statements.
Access to capital, or lack thereof, is a major risk and there is no
assurance that the Company will be able to raise required working
capital. Factors which could cause actual results to differ
materially from those estimated by the Company include, but are not
limited to, government regulation, managing and maintaining growth,
the effect of adverse publicity, litigation, competition and other
factors which may be identified from time to time in the Companys
public announcements and filings. There is no assurance that
existing capital is sufficient for the Companys needs or that it
will need to attempt to raise additional capital. There is no
assurance that any planned corporate activity, business venture, or
initiative will be pursued, or if pursued, will be successful.
There is no assurance that any water based product will promote,
assist, or maintain any beneficial human health conditions
whatsoever. There is no assurance that the infusion of vitamins in
the water based personal lubricant will provide any increase in
bioavailability to any individual person. There is no assurance
that provisional patent-pending applications will result in granted
patents, or that competing companies, in their normal course of
business, might not introduce other unrelated inventions superior
to the Companys own. No statement herein has been evaluated by the
Food and Drug Administration (FDA). V-LoveTM products are not
intended to diagnose, treat, cure or prevent any disease.
The CSE has not reviewed and does not accept responsibility for
the adequacy or accuracy of this release
